How to Optimize Therapeutic Ratio in Brachytherapy of Head and Neck Squamous Cell Carcinoma?

Authors

  • Jean-Jacques Mazeron From the Centre des Tumeurs, Groupe Hospitalier Pitie -Salpetriere, Paris (J.-J. Mazeron, J.-M. Simon, C. Hardiman), and the Brachytherapy Department, Institut Gustave Roussy, Villejuif (A. Gerbaulet), France
  • Alain Gerbaulet From the Centre des Tumeurs, Groupe Hospitalier Pitie -Salpetriere, Paris (J.-J. Mazeron, J.-M. Simon, C. Hardiman), and the Brachytherapy Department, Institut Gustave Roussy, Villejuif (A. Gerbaulet), France
  • Jean-Marc Simon From the Centre des Tumeurs, Groupe Hospitalier Pitie -Salpetriere, Paris (J.-J. Mazeron, J.-M. Simon, C. Hardiman), and the Brachytherapy Department, Institut Gustave Roussy, Villejuif (A. Gerbaulet), France
  • Claire Hardiman From the Centre des Tumeurs, Groupe Hospitalier Pitie -Salpetriere, Paris (J.-J. Mazeron, J.-M. Simon, C. Hardiman), and the Brachytherapy Department, Institut Gustave Roussy, Villejuif (A. Gerbaulet), France

DOI:

https://doi.org/10.1080/028418698430296

Abstract

Considerable experience has been accumulated with low dose rate (LDR) brachytherapy in the treatment of squamous cell carcinoma of the oral cavity and oropharynx, 4 cm or less in diameter. Recent analysis of large clinical series provided data indicating that modalities of LDR brachytherapy should be optimized in treating these tumours for increasing therapeutic ratio. LDR brachytherapy is now challenged by high dose rate (HDR) brachytherapy and pulsed dose rate (PDR) brachytherapy. Preliminary results obtained with the last two modalities are discussed in comparison with those achieved with LDR brachytherapy.

Downloads

Download data is not yet available.

Downloads

Published

1998-01-01

How to Cite

Mazeron, J.-J. ., Gerbaulet, A. ., Simon, J.-M. ., & Hardiman, C. . (1998). How to Optimize Therapeutic Ratio in Brachytherapy of Head and Neck Squamous Cell Carcinoma?. Acta Oncologica, 37(6), 583–591. https://doi.org/10.1080/028418698430296